CWA Asset Management Group LLC Buys 8,733 Shares of HCA Healthcare, Inc. $HCA

CWA Asset Management Group LLC grew its stake in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 1,062.4% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 9,555 shares of the company’s stock after buying an additional 8,733 shares during the quarter. CWA Asset Management Group LLC’s holdings in HCA Healthcare were worth $4,461,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Norges Bank bought a new position in HCA Healthcare in the second quarter valued at about $1,152,408,000. Pacer Advisors Inc. increased its stake in shares of HCA Healthcare by 6,115.3% in the third quarter. Pacer Advisors Inc. now owns 911,096 shares of the company’s stock valued at $388,309,000 after buying an additional 896,437 shares during the period. Viking Global Investors LP boosted its position in HCA Healthcare by 58.5% during the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after buying an additional 690,773 shares during the period. Danske Bank A S acquired a new position in HCA Healthcare in the 3rd quarter valued at approximately $115,530,000. Finally, Zurich Insurance Group Ltd FI lifted its holdings in shares of HCA Healthcare by 3,755.9% during the third quarter. Zurich Insurance Group Ltd FI now owns 269,912 shares of the company’s stock worth $115,036,000 after purchasing an additional 262,912 shares during the period. Institutional investors own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In other news, SVP Christopher F. Wyatt sold 4,000 shares of the company’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the transaction, the senior vice president directly owned 44,379 shares of the company’s stock, valued at $22,411,395. This represents a 8.27% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Jennifer Berres sold 8,020 shares of HCA Healthcare stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the completion of the sale, the senior vice president directly owned 11,993 shares of the company’s stock, valued at approximately $6,171,357.94. The trade was a 40.07% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 15,214 shares of company stock valued at $7,797,595. 1.30% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on HCA. TD Cowen raised their target price on HCA Healthcare from $529.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, March 10th. Wall Street Zen cut HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 14th. Argus upped their target price on HCA Healthcare from $530.00 to $560.00 and gave the company a “buy” rating in a report on Friday, February 6th. The Goldman Sachs Group raised their price target on shares of HCA Healthcare from $520.00 to $558.00 and gave the stock a “buy” rating in a report on Wednesday, January 28th. Finally, Royal Bank Of Canada increased their price objective on shares of HCA Healthcare from $525.00 to $555.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 28th. Sixteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $537.73.

View Our Latest Analysis on HCA Healthcare

HCA Healthcare Price Performance

NYSE HCA opened at $493.61 on Friday. The stock has a market capitalization of $110.36 billion, a P/E ratio of 17.39, a P/E/G ratio of 1.52 and a beta of 1.34. HCA Healthcare, Inc. has a one year low of $314.43 and a one year high of $556.52. The business has a 50 day simple moving average of $510.01 and a 200 day simple moving average of $473.55.

HCA Healthcare (NYSE:HCAGet Free Report) last announced its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping the consensus estimate of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The company had revenue of $19.51 billion during the quarter, compared to the consensus estimate of $19.67 billion. During the same quarter last year, the firm posted $6.22 EPS. The company’s quarterly revenue was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be issued a dividend of $0.78 per share. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Tuesday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.99%.

HCA Healthcare News Roundup

Here are the key news stories impacting HCA Healthcare this week:

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Further Reading

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.